Kai E. Kisand
Impact in
- Immunology top 0.2%
- Immunodeficiency and Autoimmune Disorders
- interferon and immune responses
- T-cell and B-cell Immunology
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Immunology 79
- Immunodeficiency and Autoimmune Disorders 39
- T-cell and B-cell Immunology 30
- interferon and immune responses 18
-
- SARS-CoV-2 and COVID-19 Research 15
- COVID-19 Clinical Research Studies 9
- Co-authors
- Pärt Peterson (63 shared papers)Liina Tserel (19 shared papers)Martti Laan (15 shared papers)Ana Rebane (10 shared papers)Jaanika Kärner (10 shared papers)Mario Saare (10 shared papers)Liis Haljasmägi (13 shared papers)Hamish S. Scott (6 shared papers)
- Journals
- Frontiers in Immunology (9 papers)European Journal of Immunology (8 papers)The Journal of Experimental Medicine (7 papers)Nature (5 papers)Journal of Clinical Immunology (5 papers)
- Partner nations
- EstoniaFranceUnited States
In The Last Decade
Kai E. Kisand
126 papers receiving 12.4k citations
Kai E. Kisand's Hit Papers
Peers
Comparison fields: 5 of 128
- Immunology 5.1k
- Infectious Diseases 4.9k
- Neurology 579
- Genetics 1.1k
- Rheumatology 507
Countries citing papers authored by Kai E. Kisand
This map shows the geographic impact of Kai E. Kisand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai E. Kisand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai E. Kisand more than expected).
Fields of papers citing papers by Kai E. Kisand
This network shows the impact of papers produced by Kai E. Kisand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai E. Kisand. The network helps show where Kai E. Kisand may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai E. Kisand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 3 | 2020 | 754 | |
| 4 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 5 | 2010 | 551 | |
| 6 | Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Hit paper breakdown → | 2021 | 477 |
| 7 | Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study Hit paper breakdown → | 2021 | 458 |
| 8 | 2016 | 450 | |
| 9 | 2013 | 371 | |
| 10 | Human genetic and immunological determinants of critical COVID-19 pneumonia Hit paper breakdown → | 2022 | 282 |
| 11 | 2021 | 244 | |
| 12 | 2016 | 239 | |
| 13 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 14 | 2022 | 145 | |
| 15 | 2015 | 142 | |
| 16 | 2022 | 124 | |
| 17 | 2011 | 118 | |
| 18 | 2008 | 100 | |
| 19 | 2022 | 100 | |
| 20 | 2012 | 98 |
About Kai E. Kisand
Kai E. Kisand is a scholar working on Immunology, Infectious Diseases, Genetics, Hepatology and Rheumatology, having authored 130 papers that have together received 12.6k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (39 papers), T-cell and B-cell Immunology (30 papers), interferon and immune responses (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (9 papers), Genetic Associations and Epidemiology (9 papers), Systemic Lupus Erythematosus Research (7 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Immunology (5.1k citations), Infectious Diseases (4.9k citations), Neurology (579 citations), Genetics (1.1k citations) and Rheumatology (507 citations). Kai E. Kisand has collaborated with scholars based in Estonia, France and United States. Frequent co-authors include Pärt Peterson, Liina Tserel, Martti Laan, Ana Rebane, Jaanika Kärner, Mario Saare, Liis Haljasmägi, Hamish S. Scott, Lili A. Milani and Anna Pauliina Rumm. Their work appears in journals such as Frontiers in Immunology, European Journal of Immunology, The Journal of Experimental Medicine, Nature and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.